References
- Tissier, H. (1900) Recherchers sur la flora intestinale normale et pathologique du nourisson. University of Paris, Paris.
- Jian, W., L. Zhu, and X. Dong (2001) New approach to phylogenetic analysis of the genus Bifidobacterium based on partial HSP60 gene sequences. Int. J. Syst. Evol. Microbiol. 51: 1633-1638. https://doi.org/10.1099/00207713-51-5-1633
- Ward, P. and D. Roy (2005) Review of molecular methods for identification, characterization and detection of bifidobacteria. Lait. 85: 23-32. https://doi.org/10.1051/lait:2004024
- Satokari, R. M., E. E. Vaughan, H. Smidt, M. Saarela, J. Matto, and W. M. de Vos (2003) Molecular approaches for the detection and identification of bifidobacteria and lactobacilli in the human gastrointestinal tract. Syst. Appl. Microbiol. 26: 572-584. https://doi.org/10.1078/072320203770865882
- Coeuret, V., M. Gueguen, and J. P. Vernoux (2004) Numbers and strains of lactobacilli in some probiotic products. Int. J. Food Microbiol. 97: 147-156. https://doi.org/10.1016/j.ijfoodmicro.2004.04.015
- Berg, R. D. (1996) The indigenous gastrointestinal microflora. Trends Microbiol. 4: 430-435. https://doi.org/10.1016/0966-842X(96)10057-3
- Homma, N. (1998) Bifidobacteria as a resistance factor in human beings. Bifidobact. Microfl. 7: 35-43.
- Berrada, N., J. F. Lemeland, G. Laroche, P. Thouvenot, and M. Piaia (1991) Bifidobacterium from fermented milks: survival during gastric transit. J. Dairy Sci. 74: 409-413. https://doi.org/10.3168/jds.S0022-0302(91)78183-6
- Bezkorovainy, A. (2001) Probiotics: determinants of survival and growth in the gut. Am. J. Clin. Nutr. 73: 399S-405S. https://doi.org/10.1093/ajcn/73.2.399s
- Kim, N. J., S. J. Park, E. M. Yum, H. Y. Kim, S. H. Lee, J. H. Min, M. S. Park, and G. E. Ji (2003) Effect of Bifidobacterium-fermented soy hypocotyls intake on the composition of human large intestinal bacteria in the elderly. Food Sci. Biotechnol. 12: 178-179.
- Kullen, M. J., M. M. Amann, M. J. O'Shaughnessy, D. J. O'Sullivan, F. F. Busta, and L. J. Brady (1997) Differentiation of ingested and endogenous bifidobacteria by DNA fingerprinting demonstrates the survival of an unmodified strain in the gastrointestinal tract of humans. J. Nutr. 127: 89-94. https://doi.org/10.1093/jn/127.1.89
- Bouvier, M., S. Meance, C. Bouley, J. L. Berta, and J. C. Grimaud (2001) Effects of consumption of a milk fermented by the probiotic strain bifidobacterium animalis DN-173010 on colonic transit times in healthy humans. Biosci. Microflora. 20: 43-48. https://doi.org/10.12938/bifidus1996.20.43
- Marteau, P., E. Cuillerier, S. Meance, M. F. Gerhardt, A. Myara, M. Bouvier, C. Bouley, F. Tondu, G. Bommelaer, and J. C. Grimaud (2002) Bifidobacterium animalisstrain DN-173 010 shortens the colonic transit time in healthy women: a double-blind, randomized, controlled study. Aliment. Pharmacol. Ther. 16: 587-593. https://doi.org/10.1046/j.1365-2036.2002.01188.x
- Meance, S., C. Cayuela, A. Raimondi, P. Turchet, C. Lucas, and A. J. M. (2003) Recent advances in the use of functional foods: effects of the commercial fermented milk with Bifidobacterium animalis strain DN-173 010 and yoghurt strains on gut transit time in the elderly. Microbial. Ecol. Health Disease 15: 15-22. https://doi.org/10.1080/08910600310015565
- Lievin, V., I. Peiffer, S. Hudault, F. Rochat, D. Brassart, J. R. Neeser, and A. L. Servin (2000) Bifidobacterium strains from resident infant human gastrointestinal microflora exert antimicrobial activity. Gut 47: 646-652. https://doi.org/10.1136/gut.47.5.646
- Fujiwara, S., H. Hashiba, T. Hirota, and J. F. Forstner (1997) Proteinaceous factor(s) in culture supernatant fluids of bifidobacteria which prevents the binding of enterotoxigenic Escherichia coli to gangliotetraosylceramide. Appl. Environ. Microbiol. 63: 506-512.
- Gagnon, M., E. E. Kheadr, G. Le Blay, and I. Fliss (2004) In vitro inhibition of Escherichia coli O157: H7 by bifidobacterial strains of human origin. Int. J. Food Microbiol. 92: 69-78. https://doi.org/10.1016/j.ijfoodmicro.2003.07.010
- Moroni, O., E. Kheadr, Y. Boutin, C. Lacroix, and I. Fliss (2006) Inactivation of adhesion and invasion of food-borne Listeria monocytogenes by bacteriocinproducing Bifidobacterium strains of human origin. Appl. Environ. Microbiol. 72: 6894-6901. https://doi.org/10.1128/AEM.00928-06
- Lee, J. H., V. N. Karamychev, S. A. Kozyavkin, D. Mills, A. R. Pavlov, N. V. Pavlova, N. N. Polouchine, P. M. Richardson, V. V. Shakhova, A. I. Slesarev, B. Weimer, and D. J. O'Sullivan (2008) Comparative genomic analysis of the gut bacterium Bifidobacterium longum reveals loci susceptible to deletion during pure culture growth. BMC Genomics 9: 247. https://doi.org/10.1186/1471-2164-9-247
- Otte, J. M., E. Cario, and D. K. Podolsky (2004) Mechanisms of cross hyporesponsiveness to Toll-like receptor bacterial ligands in intestinal epithelial cells. Gastroenterology 126: 1054-1070. https://doi.org/10.1053/j.gastro.2004.01.007
- Tanaka, K. and H. Ishikawa (2004) Role of intestinal bacterial flora in oral tolerance induction. Histol. Histopathol. 19: 907-914.
- Sudo, N., S. Sawamura, K. Tanaka, Y. Aiba, C. Kubo, and Y. Koga (1997) The requirement of intestinal bacterial flora for the development of an IgE production system fully susceptible to oral tolerance induction. J. Immunol. 159: 1739-1745.
- Delneste, Y., A. Donnet-Hughes, and E. J. Schiffrin (1998) Functional foods: mechanisms of action on immunocompetent cells. Nutr. Rev. 56: S93-98.
- Blum, S., S. Alvarez, D. Haller, P. Perez, and E. J. Schiffrin (1999) Intestinal microflora and the interaction with immunocompetent cells. Anton. Leeuw. 76: 199-205. https://doi.org/10.1023/A:1002009807580
- MacDonald, T. T., and S. Pettersson (2000) Bacterial regulation of intestinal immune responses. Inflamm. Bowel Dis. 6: 116-122. https://doi.org/10.1097/00054725-200005000-00008
- Bjorksten, B., P. Naaber, E. Sepp, and M. Mikelsaar (1999) The intestinal microflora in allergic Estonian and Swedish 2-year-old children. Clin. Exp. Allergy 29: 342-346. https://doi.org/10.1046/j.1365-2222.1999.00560.x
- Bjorksten, B., E. Sepp, K. Julge, T. Voor, and M. Mikelsaar (2001) Allergy development and the intestinal microflora during the first year of life. J. Allergy Clin. Immunol. 108: 516-520. https://doi.org/10.1067/mai.2001.118130
- Kalliomki, M., P. Kirjavainen, E. Eorola, P. Kero, S. Salminen, and E. Isolauri (2001) Distinct patterns of neonatal gut microflora in infants in whom atopy was and was not developing. J. Allergy Clin. Immunol. 107: 129-134. https://doi.org/10.1067/mai.2001.111237
- Watanabe, S., Y. Narisawa, S. Arase, H. Okamatsu, T. Ikenaga, and Y. Tagira (2003) Differences in fecal microflora between patients with atopic dermatitis and healthy control subjects. J. Allergy Clin. Immunol. 111: 587-591. https://doi.org/10.1067/mai.2003.105
- He, F., A. C. Ouwehand, E. Isolauri, H. Hashimoto, Y. Benno, and S. Salminen (2001) Comparison of mucosal adhesion and species identification of bifidobacteria isolated from healthy and allergic infants. FEMS Immunol. Med. Microbiol. 30: 43-47. https://doi.org/10.1111/j.1574-695X.2001.tb01548.x
- Sakata, H., H. Yoshioka, and K. Fujita (1985) Development of the intestinal flora in very low birth weight infants compared to normal full-term newborns. Eur. J. Pediatr. 144: 186-190. https://doi.org/10.1007/BF00451911
- Kitajima, H., Y. Sumida, R. Tanaka, N. Yuki, H. Takayama, and M. Fujimura (1997) Early administration of Bifidobacterium breve to preterm infants: randomised controlled trial. Arch. Dis. Child Fetal Neonatal Ed. 76: F101-107. https://doi.org/10.1136/fn.76.2.F101
- Lin, H. C., B. H. Su, A. C. Chen, T. W. Lin, C. H. Tsai, T. F. Yeh, and W. Oh (2005) Oral probiotics reduce the incidence and severity of necrotizing enterocolitis in very low birth weight infants. Pediatrics 115: 1-4. https://doi.org/10.1542/peds.2004-1463
- Bin-Nun, A., R. Bromiker, M. Wilschanski, M. Kaplan, B. Rudensky, M. Caplan, and C. Hammerman (2005) Oral probiotics prevent necrotizing enterocolitis in very low birth weight neonates. J. Pediatr. 147: 192-196. https://doi.org/10.1016/j.jpeds.2005.03.054
- Dani, C., R. Biadaioli, G. Bertini, E. Martelli, and F. F. Rubaltelli (2002) Probiotics feeding in prevention of urinary tract infection, bacterial sepsis and necrotizing enterocolitis in preterm infants. A prospective doubleblind study. Biol. Neonate. 82: 103-108. https://doi.org/10.1159/000063096
- Weizman, Z., G. Asli, and A. Alsheikh (2005) Effect of a probiotic infant formula on infections in child care centers: comparison of two probiotic agents. Pediatrics 115: 5-9. https://doi.org/10.1542/peds.2004-1815
- Thibault, H., C. Aubert-Jacquin, and O. Goulet (2004) Effects of long-term consumption of a fermented infant formula (with Bifidobacterium breve c50 and Streptococcus thermophilus 065) on acute diarrhea in healthy infants. J. Pediatr. Gastroenterol. Nutr. 39: 147-152. https://doi.org/10.1097/00005176-200408000-00004
- Saavedra, J. M., A. Abi-Hanna, N. Moore, and R. H. Yolken (2004) Long-term consumption of infant formulas containing live probiotic bacteria: tolerance andsafety. Am. J. Clin. Nutr. 79: 261-267. https://doi.org/10.1093/ajcn/79.2.261
- Allen, S. J., B. Okoko, E. G. Martinez, G. V. Gregorio, and L. F. Dans (2004) Probiotics for treating infectious diarrhoea. Cochrane Cochrane Database of Systematic Reviews. Art. No. CD003048.
- Shin, K. M., J. Y. Byun, M. S. Park, G. E. Ji, and D. S. Kim (2003) Effect of Lactic acid bacteria on rotaviral enteritis. Proceedings of the annual meeting of The Korean Society of Food Service Sanitation. November 08, Seoul, Korea.
- Sampson, H. A., L. Mendelson, and J. P. Rosen (1992) Fatal and near-fatal anaphylactic reactions to food in children and adolescents. N. Engl. J. Med. 327: 380-384. https://doi.org/10.1056/NEJM199208063270603
- Ogura, Y., H. Ogura, and N. Zusi (2001) The incidence of food allergy in atopic dermatitis. Arerugi. 50: 621-628.
- Lee, S. I., M. H. Shin, H. B. Lee, J. S. Lee, B. K. Son, Y. Y. Koh, K. E. Kim, and Y. O. Ahn (2001) Prevalences of symptoms of asthma and other allergic diseases in korean children: a nationwide questionnaire survey. J. Korean Med. Sci. 16: 155-164. https://doi.org/10.3346/jkms.2001.16.2.155
- Flohr, C., D. Pascoe, and H. C. Williams (2005) Atopic dermatitis and the 'hygiene hypothesis': too clean to be true? Br. J. Dermatol. 152: 202-216. https://doi.org/10.1111/j.1365-2133.2004.06436.x
- Braun-Fahrlander, C., J. Riedler, U. Herz, W. Eder, M. Waser, L. Grize, S. Maisch, D. Carr, F. Gerlach, A. Bufe, R. P. Lauener, R. Schierl, H. Renz, D. Nowak, and E. von Mutius (2002) Environmental exposure to endotoxin and its relation to asthma in school-age children. N. Engl. J. Med. 347: 869-877. https://doi.org/10.1056/NEJMoa020057
- Hansen, G., J. J. McIntire, V. P. Yeung, G. Berry, G. J. Thorbecke, L. Chen, R. H. DeKruyff, and D. T. Umetsu (2000) CD4 (+) T helper cells engineered to produce latent TGF-beta1 reverse allergen-induced airway hyperreactivity and inflammation. J. Clin. Invest. 105: 61-70. https://doi.org/10.1172/JCI7589
- Prescott, S. L. (2003) Allergy: the price we pay for cleaner living? Ann. Allergy Asthma Immunol. 90: 64-70. https://doi.org/10.1016/S1081-1206(10)61663-8
- Perez-Machado, M. A., P. Ashwood, M. A. Thomson, F. Latcham, R. Sim, J. A. Walker-Smith, and S. H. Murch (2003) Reduced transforming growth factor-beta1- producing T cells in the duodenal mucosa of children with food allergy. Eur. J. Immunol. 33: 2307-2315. https://doi.org/10.1002/eji.200323308
- Teitelbaum, J. E. and W. A. Walker (2002) Nutritional impact of pre- and probiotics as protective gastrointestinal organisms. Annu. Rev. Nutr. 22: 107-138. https://doi.org/10.1146/annurev.nutr.22.110901.145412
- Hattori, K., A. Yamamoto, M. Sasai, S. Taniuchi, T. Kojima, Y. Kobayashi, H. Iwamoto, K. Namba, and T. Yaeshima (2003) Effects of administration of bifidobacteria on fecal microflora and clinical symptoms in infants with atopic dermatitis. Arerugi. 52: 20-30.
- Isolauri, E., T. Arvola, Y. Sutas, E. Moilanen, and S. Salminen (2000) Probiotics in the management of atopic eczema. Clin. Exp. Allergy 30: 1604-1610.
- Rosenfeldt, V., E. Benfeldt, S. D. Nielsen, K. F. Michaelsen, D. L. Jeppesen, N. H. Valerius, and A. Paerregaard (2003) Effect of probiotic Lactobacillus strains in children with atopic dermatitis. J. Allergy Clin. Immunol. 111: 389-395. https://doi.org/10.1067/mai.2003.389
- Kim, H., K. Kwack, D. Y. Kim, and G. E. Ji (2005) Oral probiotic bacterial administration suppressed allergic responses in an ovalbumin-induced allergy mouse model. FEMS Immunol. Med. Microbiol. 45: 259-267. https://doi.org/10.1016/j.femsim.2005.05.005
- Kim, H., S. Y. Lee, and G. E. Ji (2005) Timing of Bifidobacterium administration influences the development of allergy to ovalbumin in mice. Biotechnol. Lett. 27: 1361-1367. https://doi.org/10.1007/s10529-005-3682-9
- Kim, J. Y., J. H. Kwon, S. H. Ahn, S. I. Lee, Y. S. Han, Y. O. Choi, S. Y. Lee, K. M. Ahn, and G. E. Ji (2010) Effect of probiotic mix (Bifidobacterium bifidum, Bifidobacterium lactis, Lactobacillus acidophilus) in the primary prevention of eczema: a double-blind, randomized, placebo-controlled trial. Pediatr. Allergy Immunol. 21: e386-393. https://doi.org/10.1111/j.1399-3038.2009.00958.x
- Kim, J. Y., Y. O. Choi, and G. E. Ji (2008) Effect of oral probiotics (Bifidobacterium lactis AD011 and Lactobacillus acidophilus AD031) administration on ovalbumin-induced food allergy mouse model. J. Microbiol. Biotechnol. 18: 1393-1400.
- Sgorbati, B., V. Scardovi, and D. J. Leblanc (1982) Plasmids in the genus Bifidobacterium. J. Gen. Microbiol. 128: 2121-2131.
- Corneau, N., E. Emond, and G. LaPointe (2004) Molecular characterization of three plasmids from Bifidobacterium longum. Plasmid 51: 87-100. https://doi.org/10.1016/j.plasmid.2003.12.003
- Guglielmetti, S., M. Karp, D. Mora, I. Tamagnini, and C. Parini (2007) Molecular characterization of Bifidobacterium longum biovar longum NAL8 plasmids and construction of a novel replicon screening system. Appl. Microbiol. Biotechnol. 74: 1053-1061. https://doi.org/10.1007/s00253-006-0755-1
- Lee, J. H. and D. J. O'Sullivan (2006) Sequence analysis of two cryptic plasmids from Bifidobacterium longum DJO10A and construction of a shuttle cloning vector. Appl. Environ. Microbiol. 72: 527-535. https://doi.org/10.1128/AEM.72.1.527-535.2006
- O'Riordan, K. and G. F. Fitzgerald (1999) Molecular characterisation of a 5.75-kb cryptic plasmid from Bifidobacterium breve NCFB 2258 and determination of mode of replication. FEMS Microbiol. Lett. 174: 285-294. https://doi.org/10.1111/j.1574-6968.1999.tb13581.x
- Park, M. S., D. W. Shin, K. H. Lee, and G. E. Ji (1999) Sequence analysis of plasmid pKJ50 from Bifidobacterium longum. Microbiology 145: 585-592. https://doi.org/10.1099/13500872-145-3-585
- Park, M. S., D. W. Shin, K. H. Lee, and G. E. Ji (2000) Characterization of plasmid pKJ36 from Bifidobacterium longum and construction of an E. coli-Bifidobacterium shuttle vector. J. Microbiol. Biotechnol. 10: 312-320.
- Park, M. S., H. W. Moon, and G. E. Ji (2003) Molecular characterization of plasmid from Bifidobacterium longum. J. Microbiol. Biotechnol. 13: 457-462.
- Sangrador-Vegas, A., C. Stanton, D. van Sinderen, G. F. Fitzgerald, and R. P. Ross (2007) Characterization of plasmid pASV479 from Bifidobacterium pseudolongum subsp. globosum and its use for expression vector construction. Plasmid 58: 140-147. https://doi.org/10.1016/j.plasmid.2007.02.004
- Tanaka, K., K. Samura, and Y. Kano (2005) Structural and functional analysis of pTB6 from Bifidobacterium longum. Biosci. Biotechnol. Biochem. 69: 422-425. https://doi.org/10.1271/bbb.69.422
- Moon, G. S., U. Wegmann, A. P. Gunning, M. J. Gasson, and A. Narbad (2009) Isolation and characterization of a theta-type cryptic plasmid from Bifidobacterium longum FI10564. J. Microbiol. Biotechnol. 19: 403-408. https://doi.org/10.4014/jmb.0806.378
- Moon, G. S., Y. R. Pyun, M. S. Park, G. E. Ji, and W. J. Kim (2005) Secretion of recombinant pediocin PA-1 by Bifidobacterium longum, using the signal sequence for bifidobacterial alpha-amylase. Appl. Environ. Microbiol. 71: 5630-5632. https://doi.org/10.1128/AEM.71.9.5630-5632.2005
- Park, M. S., J. M. Seo, J. Y. Kim, and G. E. Ji (2005) Heterologous gene expression and secretion in Bifidobacterium longum. Lait 85: 1-8. https://doi.org/10.1051/lait:2004027
- Rossi, M., P. Brigidi, and D. Matteuzzi (1998) Improved cloning vectors for Bifidobacterium spp. Lett. Appl. Microbiol. 26: 101-104. https://doi.org/10.1111/j.1574-6941.1998.tb00496.x
- Park, M. S., B. Kwon, J. J. Shim, C. S. Huh, and G. E. Ji (2008) Heterologous expression of cholesterol oxidase in Bifidobacterium longumunder the control of 16S rRNA gene promoter of bifidobacteria. Biotechnol. Lett. 30: 165-172.
- Kim, J. Y., Y. Wang, M. S. Park, and G. E. Ji (2010) Improvement of transformation efficiency through in vitro methylation and SacII site mutation of plasmid vector in Bifidobacterium longum MG1. J. Microbiol. Biotechnol. 20: 1022-1026. https://doi.org/10.4014/jmb.1003.03014
- Yazawa, K., M. Fujimori, J. Amano, Y. Kano, and S. Taniguchi (2000) Bifidobacterium longum as a delivery system for cancer gene therapy: selective localization and growth in hypoxic tumors. Cancer Gene Ther. 7: 269-274. https://doi.org/10.1038/sj.cgt.7700122
- Fujimori, M. (2006) Genetically engineered bifidobacterium as a drug delivery system for systemic therapy of metastatic breast cancer patients. Breast Cancer 13: 27-31. https://doi.org/10.2325/jbcs.13.27
- Yi, C., Y. Huang, Z. Y. Guo, and S. R. Wang (2005) Antitumor effect of cytosine deaminase/5-fluorocytosine suicide gene therapy system mediated by Bifidobacterium infantison melanoma. Acta Pharmacol. Sin. 26: 629-634. https://doi.org/10.1111/j.1745-7254.2005.00094.x
- Fu, G. F., X. Li, Y. Y. Hou, Y. R. Fan, W. H. Liu, and G. X. Xu (2005) Bifidobacterium longumas an oral delivery system of endostatin for gene therapy on solid liver cancer. Cancer Gene Ther. 12: 133-140. https://doi.org/10.1038/sj.cgt.7700758
- Xu, Y. F., L. P. Zhu, B. Hu, G. F. Fu, H. Y. Zhang, J. J. Wang, and G. X. Xu (2007) A new expression plasmid in Bifidobacterium longumas a delivery system of endostatin for cancer gene therapy. Cancer Gene Ther. 14: 151-157. https://doi.org/10.1038/sj.cgt.7701003
- Long, R. T., W. S. Zeng, L. Y. Chen, J. Guo, Y. Z. Lin, Q. S. Huang, and S. Q. Luo (2010) Bifidobacteriumas an oral delivery carrier of oxyntomodulin for obesity therapy: inhibitory effects on food intake and body weight in overweight mice. Int. J. Obes (Lond). 34: 712-719. https://doi.org/10.1038/ijo.2009.277
- Joint FAO/WHO (2001) Expert Consultation on "Evaluation of health and nutritional properties of probiotics in food including powder milk with live lactic acid bacteria". pp. 1-32
- Report of Joint FAO/WHO (2002) Working Group on "Drafting guide lines for the evaluation of probiotics in food".
- Natural Health Products Directorate (2003) "Evidence for safety and efficacy of finished natural health products".
- Notario, R., N. Leardini, N. Borda, T. Gambande, and H. Cerutti (2003) Hepatic abscess and bacteremia due to Lactobacillus rhamnosus. Rev. Argent. Microbiol. 35: 100-101.
- Rautio, M., H. Jousimies-Somer, H. Kauma, I. Pietarinen, M. Saxelin, S. Tynkkynen, and M. Koskela (1999) Liver abscess due to a Lactobacillus rhamnosusstrain indistinguishable from L. rhamnosus strain GG. Clin. Infect. Dis. 28: 1159-1160. https://doi.org/10.1086/514766
- Mackay, A. D., M. B. Taylor, C. C. Kibbler, and J. M. Hamilton-Miller (1999) Lactobacillus endocarditis caused by a probiotic organism. Clin. Microbiol. Infect 5: 290-292. https://doi.org/10.1111/j.1469-0691.1999.tb00144.x
- Munoz, P., E. Bouza, M. Cuenca-Estrella, J. M. Eiros, M. J. Perez, M. Sanchez-Somolinos, C. Rincon, J. Hortal, and T. Pelaez (2005) Saccharomyces cerevisiae fungemia: an emerging infectious disease. Clin Infect Dis. 40: 1625-1634. https://doi.org/10.1086/429916
- Presterl, E., W. Kneifel, H. K. Mayer, M. Zehetgruber, A. Makristathis, and W. Graninger (2001) Endocarditis by Lactobacillus rhamnosusdue to yogurt ingestion? Scand. J. Infect. Dis. 33: 710-714. https://doi.org/10.1080/00365540110026953
- Burkhardt, O., T. Kohnlein, M. Pletz, and T. Welte (2005) Saccharomyces boulardiiinduced sepsis: successful therapy with voriconazole after treatment failure with fluconazole. Scand. J. Infect Dis. 37: 69-72. https://doi.org/10.1080/00365540510026454